1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death
Ville‐Petteri Mäkinen(Helsinki University Hospital), Mika Ala‐Korpela(University of Oulu), Per‐Henrik Groop(University of Helsinki), Pasi Soininen(University of Eastern Finland), Maija Parkkonen(University of Helsinki), Kimmo Kaski(Aalto University), Petri Ingman(University of Turku), Carol Forsblom(University of Helsinki)
Cited by 156
Related Papers
Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals
|Nature Metabolism|2020|775
The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
|Diabetes|2009|641
Metabolomics Reveals Signature of Mitochondrial Dysfunction in Diabetic Kidney Disease
|Journal of the American Society of Nephrology|2013|578
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
|Diabetes|1999|509
Metabolic Syndrome in Type 1 Diabetes
|Diabetes Care|2005|428